Yin Xin Hua, Wang Xiao Yuan, Liu Shi Chang, Chen Xu Xu, Yan Liang, Li Liang, Le He Gao, Yang Ming, Liu Zhong Kai
Department of Spine Surgery, Hong Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, China.
Physical Examination Center, Xi'an International Medical Center Hospital, Xi'an, China.
Cell Signal. 2025 Apr;128:111636. doi: 10.1016/j.cellsig.2025.111636. Epub 2025 Jan 30.
The osteogenic differentiation potential of bone marrow mesenchymal stem cells (BM-MSCs) is critical for bone regeneration and repair. In recent years, the role of protein succinylation modification in regulating cellular metabolism has garnered increasing attention. However, its mechanism in osteogenic differentiation remains unclear.
Oxygen consumption rate (OCR) and mitochondrial ROS (mtROS) were detected to assess mitochondrial function in BM-MSCs with successive passages. Alizarin red staining and western blot experiments were used to evaluate osteogenic differentiation capacity. Succinylation modification omics and Co-IP detection were conducted to determine SIRT5-mediated desuccinylation of UQCRC2.
Bioinformatics analysis revealed that sirtuin 5 (SIRT5) expression is upregulated with multiple rounds of BM-MSCs' passages, and is associated with biological pathways such as oxidative phosphorylation (OXPHOS), cellular senescence, and inhibition of osteogenic differentiation. Experiments in vitro confirmed the up-regulation of SIRT5 and the suppression of osteogenic differentiation with the increased times of BM-MSCs' passages. Overexpression of SIRT5 enhanced OXPHOS and elevated mtROS levels, but reduced the expression of Runx2 and osteocalcin, and decreased calcified nodules, thereby inhibiting the osteogenic differentiation of BM-MSCs. SIRT5-mediated desuccinylation of ubiquinol-cytochrome C reductase core protein 2 (UQCRC2) at the site of K250 promoted UQCRC2 translocation from cytoplasm to mitochondria, which enhanced the activity of mitochondrial respiratory complex III. It further increased mtROS, accelerated cellular senescence and inhibited the osteogenic differentiation of BM-MSCs.
SIRT5 reduces succinylation modification of UQCRC2, promotes mitochondrial respiration and mtROS, and thus reduces the osteogenic differentiation ability of BM-MSCs cells. SIRT5 might be a potential target to prevent the suppression of osteogenic differentiation of of BM-MSCs after multiple rounds passages.
骨髓间充质干细胞(BM-MSCs)的成骨分化潜能对骨再生和修复至关重要。近年来,蛋白质琥珀酰化修饰在调节细胞代谢中的作用日益受到关注。然而,其在成骨分化中的机制仍不清楚。
检测氧消耗率(OCR)和线粒体活性氧(mtROS)以评估连续传代的BM-MSCs中的线粒体功能。采用茜素红染色和蛋白质印迹实验评估成骨分化能力。进行琥珀酰化修饰组学和免疫共沉淀检测以确定SIRT5介导的泛醌-细胞色素C还原酶2(UQCRC2)去琥珀酰化。
生物信息学分析显示,随着BM-MSCs传代次数增加,沉默调节蛋白5(SIRT5)表达上调,且与氧化磷酸化(OXPHOS)、细胞衰老和成骨分化抑制等生物学途径相关。体外实验证实随着BM-MSCs传代次数增加,SIRT5上调且成骨分化受到抑制。SIRT5过表达增强了OXPHOS并提高了mtROS水平,但降低了Runx2和骨钙素的表达,并减少了钙化结节,从而抑制了BM-MSCs的成骨分化。SIRT5介导的泛醌-细胞色素C还原酶核心蛋白2(UQCRC2)在K250位点的去琥珀酰化促进了UQCRC2从细胞质向线粒体的转运,增强了线粒体呼吸复合物III的活性。这进一步增加了mtROS,加速了细胞衰老并抑制了BM-MSCs的成骨分化。
SIRT5降低UQCRC2的琥珀酰化修饰,促进线粒体呼吸和mtROS生成,从而降低BM-MSCs细胞的成骨分化能力。SIRT5可能是防止BM-MSCs多次传代后成骨分化受抑制的潜在靶点。